A potential therapeutic strategy for capillary hemangioma with new anti-vascular endothelial growth factor (anti-VEGF) agents

Med Hypotheses. 2007;69(4):951. doi: 10.1016/j.mehy.2007.02.017. Epub 2007 Apr 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Hemangioma, Capillary / drug therapy*
  • Humans
  • Infant
  • Infant, Newborn
  • Receptors, Vascular Endothelial Growth Factor / immunology
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Vascular Endothelial Growth Factor A
  • Receptors, Vascular Endothelial Growth Factor